Takeda receives shareholders' approval to acquire Shire
Dec 05, 2018 - Marketline Newswire
Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire.
The Japanese pharmaceutical company received at least 88% of votes exercised in favour of the proposal. Further, at least 87% of the votes exercised were in support of the company's proposal to appoint three of Shire's existing external directors to its board.Takeda Pharmaceutical president and CEO Christophe Weber said: "With sharehold...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
